Protection by cAMP and cGMP phosphodiesterase inhibitors of diazinon-induced hyperglycemia and oxidative/nitrosative stress in rat Langerhans islets cells: Molecular evidence for involvement of non-cholinergic mechanisms

Pesticide Biochemistry and Physiology

Volumn 87, Issue 3, 2007, Pages 261-270

  Ghafour Rashidi, Zahra ^a   Dermenaki Farahani, Elham ^a   Aliahmadi, Atousa ^a   Esmaily, Hadi ^a   Mohammadirad, Azadeh ^a   Ostad, Seyed Nasser ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute; Diazinon; Glucose; Hyperglycemia; Insulin; Langerhans islets; Nitrosative stress; Oxidative stress; Pancreas; Phosphodiesterase inhibitors; Rat; Sildenafil; Theophylline; Toxicity; Tumor necrosis factor

Indexed keywords

RATTUS;

EID: 33846663876     PISSN: 00483575     EISSN: 10959939     Source Type: Journal    
DOI: 10.1016/j.pestbp.2006.08.007     Document Type: Article

References (65)

1. Barr D.B., Bravo R., Weerasekera G., Caltabiano L.M., Whitehead Jr. R.D., Olsson A.O., Caudill S.P., Schober S.E., Pirkle J.L., Sampson E.J., Jackson R.J., and Needham L.L. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ. Health. Perspect. 112 (2004) 186-200
2. Casida J.E., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 17 (2004) 983-998 Review
3. Sams C., Mason H.J., and Rawbone R. Evidence for the activation of organophosphate pesticides by cytochromes P450 3A4 and 2D6 in human liver microsomes. Toxicol. Lett. 116 (2000) 217-221
4. Gordon C.J., and Mack C.M. Influence of gender on thermoregulation and ChE inhibition in the long-evans rat exposed to diazinon. J. Toxicol. Environ. Health A 66 3 (2003) 291-304
5. Poet T.S., Kousba A.A., Dennison S.L., and Timchalk C. Physiologically based pharmacokinetic/pharmacodynamic model for the organophosphorus pesticide diazinon. NeuroToxicology. 25 (2004) 1013-1030
6. Abdollahi M., Mostafalou S., Pournourmohammadi S., and Shadnia S. Oxidative stress and cholinesterase inhibition in saliva and plasma of rats following subchronic exposure to malathion. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 137 (2004) 29-34
7. Ozcan Oruc E., Uner N., Sevgiler Y., Usta D., and Durmaz H. Sublethal effects of organophosphate diazinon on the brain of Cyprinus carpio. Drug Chem. Toxicol. 29 (2006) 57-67
8. Akhgari M., Abdollahi M., Kebryaeezadeh A., Hosseini R., and Sabzevari O. Biochemical evidence for free radical-induced lipid peroxidation as a mechanism for subchronic toxicity of malathion in blood and liver of rats. Hum. Exp. Toxicol. 22 (2003) 205-211
9. Ranjbar A., Pasalar P., and Abdollahi M. Induction of oxidative stress and acetylcholinesterase inhibition in organophosphorous pesticide manufacturing workers. Hum. Exp. Toxicol. 21 (2002) 179-182
10. Abdollahi M., Soleimani F., and Kangarlou S. A review on blood glucose variations and affecting parameters. M.E. Pharmacy 11 (2003) 6-10
11. Abdollahi M., Donyavi M., Pournourmohammadi S., and Saadat M. Hyperglycemia associated with increased hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities in rat following subchronic exposure to malathion. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 137 (2004) 343-347
12. Pournourmohammadi S., Farzami B., Ostad S.N., Azizi E., and Abdollahi M. Effects of malathion subchronic exposure on rat skeletal muscle glucose metabolism. Environ. Toxicol. Pharmacol. 19 (2005) 191-196
13. Panahi P., Vosough-Ghanbari S., Pournourmohammadi S., Ostad S.N., Nikfar S., Minaie B., and Abdollah M. Stimulatory effects of malathion on the key enzymes activities of insulin secretion in Langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol. Mech. Methods 16 (2006) 161-167
14. Kalender Y., Kalender S., Uzunhisarcikli M., Ogutcu A., Acikgoz F., and Durak D. Effects of endosulfan on B cells of Langerhans islets in rat pancreas. Toxicology 200 (2004) 205-211
15. Abdollahi M., Ranjbar A., Shadnia S., Nikfar S., and Rezaie A. Pesticides and oxidative stress: a review. Med. Sci. Monit. 10 (2004) 141-147
16. Shadnia S., Azizi E., Hosseini R., Khoei S., Fouladdel S., Pajoumand P., Jalali N., and Abdollahi M. Evaluation of oxidative stress and genotoxicity in organophosphorus insecticide formulators. Hum. Exp. Toxicol. 24 (2005) 439-445
17. Andican G., Gelisgen R., Unal E., Tortum O.B., Dervisoglu S., Karahasanoglu T., and Burcak G. Oxidative stress and nitric oxide in rats with alcohol-induced acute pancreatitis. World J. Gastroenterol. 11 (2005) 2340-2345
18. Corbbet J.A., Sweetland M.A., Wang J.L., Lancaster J.R., and McDaniel M.L. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islet of Langerhans. Proc. Natl. Acad. Sci. USA 90 (1993) 1731-1735
19. Andersson A.K., Borjesson A., Sandgren J., and Sandler S. Cytokines affect PDX-1 expression, insulin and proinsulin secretion from iNOS deficient murine islets. Mol. Cell. Endocrinol. 240 (2005) 50-57
20. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., and Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44 7 (1995) 733-738
21. Ansar M.M., and Ansari M. Nitric oxide involvement in pancreatic beta cell apoptosis by glibenclamide. Nitric Oxide 14 (2006) 39-44
22. Milani E., Nikfar S., Khorasrni R., Zamani M.J., and Abdollahi M. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitiors in rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 140 (2005) 251-255
23. Rahimi R., Nikfar S., Larijani B., and Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother. 59 7 (2005) 365-373
24. Kalender S., Ogutcu A., Uzunhisarcikli M., Acikgoz F., Durak D., Ulusoy Y., and Kalender Y. Diazinon-induced hepatotoxicity and protective effect of vitamin E on some biochemical indices and ultrastructural changes. Toxicology 211 (2005) 197-206
25. S. Shadnia, M. Dasgar, S. Taghikhani, A. Mohammadirad, M. Abdollahi, Protective effects of alpha-tocopherol and N-acetyl-cysteine on diazinon-induced oxidative stress and acetylcholinesterase inhibition in rats, Toxicol. Mech. Methods (2006) in press.
26. Dal-Piaz V., and Giovannoni M.P. Phosphodiesterase 4 inhibitiors, structurally unrelated to rolipram, as promising agents for the treatment of asthuma and other pathologies. Eur. J. Med. Chem. 35 (2004) 463-480
27. Abdollahi M., Chan T.S., Subrahmanyam V., and O'Brien P.J. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol. Cell. Biochem. 252 (2003) 205-211
28. Hoseini S., Esmaily H., Mohammadirad A., and Abdollahi M. Effects of sildenafil a phosphodiesterase 5 inhibitor on rat liver cell key enzymes of gluconeogenesis and glycogenolysis. Int. J. Pharmacol. 2 (2006) 280-285
29. Abdollahi M., Fooladian F., Emami B., Zafari K., and Bahreini-Moghadam A. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum. Exp. Toxicol. 22 (2003) 587-592
30. Abdollahi M., Bahreini-Moghadam A., Emami B., Fooladian F., and Zafari K. Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 135 (2003) 331-336
31. Aghababaeian R., Ghazi-Khansari M., Abdi K., Taghadosinejad F., and Abdollahi M. Protective effects of sildenafil and dipyridamol from lead-induced lipid peroxidation in perfused rat liver. Int. J. Pharmacol. 1 (2005) 157-160
32. Ellman G.L., Courtney K.D., Andress V., and Featherston R.M. A new and rapid colorimetric determination of acethylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
33. H.U. Bergmeyer, E. Bernt, F. Schmidt, H. Stork, D-glucose, in: H.U. Bergmeyer, (Ed.), Methods of Enzymatic Analysis, vol. 3, Academic Press, New York, 1974, pp. 1196-1201.
34. Lowry O.H., Roserbrough N.J., Farr A.L., and Randell R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
35. Satho K. Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin. Chem. Acta 90 (1978) 37-43
36. Benzi I.F., and Strains S. Ferric reducing antioxidant assay. Methods Enzymol. 292 (1999) 15-27
37. International Programme on Chemical Safety. Inventory of IPCS and other WHO pesticide evaluations and summary of toxicological evalutions performed by the JMPR, WHO/PCS/02.3. World Health Organization, Geneva, (2003).
38. Gupta R.C., Milatovic D., and Dettbarn W.D. Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-alpha-phenylnitrone or vitamin E. Arch. Toxicol. 75 (2001) 346-356
39. Heitmeier M.R., Scarim A.L., and Corbett J.A. Double-stranded RNA inhibits beta-cell function and induces islet damage by stimulating beta-cell production of nitric oxide. J. Biol. Chem. 274 18 (1999) 12531-12536
40. McCabe C., Samali A., and O'brien T. Beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS. Biochem. Biophys. Res. Commun. 342 (2006) 1240-1248
41. Ueno N., Kashiwamura S., Ueda H., Okamura H., Tsuji N.M., Hosohara K., Kotani J., and Marukawa S. Role of interleukin 18 in nitric oxide production and pancreatic damage during acute pancreatitis. Shock 24 (2005) 564-570
42. Matin M.A., Husain K., and Khan S.N. Modification of diazinon-induced changes in carbohydrate metabolism by adrenalectomy in rats. Biochem. Pharmacol. 39 (1990) 1781-1786
43. Green K., Brand M.D., and Murphy M.P. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 1 (2004) S110-S118
44. Yoshitaka K., and Hideaki K. Role of oxidative stress in pancreatic β-cell dysfunction. Ann. N.Y. Acad. Sci. 1011 (2004) 168-176
45. Matsuoka T., Kajimoto Y., Watada H., Kaneto H., Kishimoto M., Umayahara Y., Fujitani Y., Kamada T., Kawamori R., and Yamasaki Y. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99 (1997) 144-150
46. Seifert J. Toxicologic significance of the hyperglycemia caused by organophosphorous insecticides. Bull. Environ. Contam. Toxicol. 67 (2001) 463-469
47. Gilon P., and Henquin J.C. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr. Rev. 22 5 (2001) 565-604
48. Guarino M.P., Correia N.C., Lautt W.W., and Macedo M.P. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G527-G532
49. Korc M. Update on diabetes mellitus. Dis. Markers 20 (2004) 161-165
50. Duttaroy A., Zimliki C.L., Gautam D., Cui Y., Mears D., and Wess J. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Diabetes 53 (2004) 1714-1720
51. Teichert-Kuliszewska K., Lawecki J., and Szymczyk T. Glycaemia and insulinaemia resulting from dichlorvos intoxication. Acta Med. Pol. 22 (1981) 303-308
52. Radfar M., Larijani B., Hadjibabaie M., Rajabipour B., Mojtahedi A., and Abdollahi M. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed. Pharmacother. 59 (2005) 302-306
53. Rodriguez-Iturbe B., Ferrebuz A., Vanegas V., Quiroz Y., Espinoza F., Pons H., and Vaziri N.D. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int. 68 (2005) 2131-2142
54. Dias-Junior C.A., Souza-Costa D.C., Zerbini T., da Rocha J.B., Gerlach R.F., and Tanus-Santos J.E. The effect of sildenafil on pulmonary embolism-induced oxidative stress and pulmonary hypertension. Anesth. Analg. 101 1 (2005) 115-120
55. Tsukagoshi H., Shimizu Y., Iwamae S., Hisada T., Ishizuka T., Iizuka K., Dobashi K., and Mori M. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir. Med. 94 (2000) 584-588
56. Grankvist K., Marklund S.L., and Taljedal I.B. CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199 (1981) 393-398
57. Lenzen S., Drinkgern J., and Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20 (1996) 463-466
58. Verghese M.W., McConnell R.T., Strickland A.B., Gooding R.C., Stimpson S.A., Yarnall D.P., Taylor J.D., and Furdon P.J. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmacol. Exp. Ther. 272 (1995) 1313-1320
59. Greten T.F., Eigler A., Sinha B., Moeller J., and Endres S. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxide. Int. J. Immunopharmacol. 17 (1995) 605-610
60. Kaur K., Sharma A.K., and Singal P.K. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 291 1 (2006) 106-113
61. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11 (1993) 165-190
62. Mascali J.J., Cvietusa P., Negri J., and Borish L. Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann. Allergy Asthma Immunol. 77 (1996) 34-38
63. Milatovic D., Gupta R.C., and Aschner M. Anticholinesterase toxicity and oxidative stress. Scientific World Journal 6 (2006) 295-310
64. Doraiswamy P.M. Non-cholinergic strategies for treating and preventing Alzheimer's disease. CNS Drugs 16 (2002) 811-824
65. Cunha G.M., Farias P.A., and Viana G.S. Evidence for the involvement of the muscarinic cholinergic system in the central actions of pentoxifylline. Behav. Pharmacol. 13 (2002) 149-156